Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston
May 03, 2023 09:00 ET
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTCQB: SRBCF) ("Sirona") is excited to announce that Dr. Geraldine Deliencourt-Godefroy,...
Axiom Exhibiting at Clinical Operations in Oncology Trials West Coast 2023
April 25, 2023 13:13 ET
|
Axiom Real-Time Metrics Inc
TORONTO, April 25, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
March 30, 2023 16:05 ET
|
GreenLight Biosciences
BOSTON, March 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA) (“GreenLight” or the “Company”), a public benefit corporation striving to deliver on the full potential of RNA to...
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
March 21, 2023 16:05 ET
|
Telesis Bio
-- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio...
PharmAla Biotech named Exclusive MDMA Supply Partner to Awakn Life Sciences
March 02, 2023 08:35 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and...
Synlogic Announces Participation in Upcoming Investor and Industry Conferences
January 24, 2023 06:57 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced it will participate in the...
Merakris Announces Review in Biomedicines Medical Journal Highlighting Therapeutic Potential of Cell-Free Amniotic Fluid
November 29, 2022 06:15 ET
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., Nov. 29, 2022 (GLOBE NEWSWIRE) -- A review published recently in the international scientific journal Biomedicines highlights the therapeutic benefits of amniotic fluid...
Bioventus Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud (BVS)
November 23, 2022 17:06 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bioventus Inc. (“Bioventus”) (NASDAQ: BVS). If you...
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
November 09, 2022 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
November 07, 2022 07:00 ET
|
Axsome Therapeutics, Inc.
Sunosi® third quarter U.S. net sales of $16.8 million Auvelity™ launched and available in U.S. pharmacies SHARP study results announced demonstrating statistically significant improvement in...